% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • cheddaman45 cheddaman45 Jun 1, 2013 10:36 PM Flag

    Rockwell Medical Announces Design of Phase III Iron Therapy Program for SFP

    "We are pleased that our positive dialogue with the FDA led to what we believe to be a robust Phase III program," stated Robert L. Chioini, Chairman, CEO and President of Rockwell. "We are very encouraged that the FDA supports our Phase III primary efficacy endpoint, which demonstrated statistical significance in our Phase IIb study. We have submitted our Phase III protocol in its entirety to the Agency and we have made significant progress in site recruitment. As a result, we anticipate commencing the Phase III program within the next 90 days."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.09+0.05(+0.83%)Oct 21 4:00 PMEDT